Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter L Stern

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
The Journal of General Virology|September 29, 1999
Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasiaHetty J Bontkes, Tanja D de Gruijl, Astrid Bijl, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigensRyan D Guest, Robert E Hawkins, Natalia Kirillova, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2015
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal AntibodiesJoshua W Wang, Subhashini Jagu, Wai-Hong Wu, et al.
International Journal of Cancer|April 29, 2006
CD8 T-cell recognition of human 5T4 oncofetal antigenLucy J C Smyth, Eyad Elkord, Taher E I Taher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccinationLucy J C Smyth, Mariëtte I E Van Poelgeest, Emma J Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancerAndreas M Kaufmann, Peter L Stern, Elaine M Rankin, et al.
Vaccine|November 16, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.
Vaccine|December 17, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.
Vaccine|December 17, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.
Vaccine|December 17, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Journal of General Virology|September 29, 1999
Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasiaHetty J Bontkes, Tanja D de Gruijl, Astrid Bijl, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigensRyan D Guest, Robert E Hawkins, Natalia Kirillova, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2015
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal AntibodiesJoshua W Wang, Subhashini Jagu, Wai-Hong Wu, et al.
International Journal of Cancer|April 29, 2006
CD8 T-cell recognition of human 5T4 oncofetal antigenLucy J C Smyth, Eyad Elkord, Taher E I Taher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccinationLucy J C Smyth, Mariëtte I E Van Poelgeest, Emma J Davidson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancerAndreas M Kaufmann, Peter L Stern, Elaine M Rankin, et al.
Vaccine|November 16, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.
Vaccine|December 17, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.
Vaccine|December 17, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.
Vaccine|December 17, 2013
Comprehensive control of human papillomavirus infections and related diseasesF Xavier Bosch, Thomas R Broker, David Forman, et al.
Pageof 9